• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中凋亡调节蛋白(bcl-2和p53)与Gleason评分之间的关系

Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer.

作者信息

Karaburun Paker S, Kilicarslan B, Ciftcioglu A M, Oztekin S, Sargin F C, Erdogru T, Baykara M

机构信息

The Faculty of Medicine, Department of Pathology, Akdeniz University, Antalya, Turkey.

出版信息

Pathol Oncol Res. 2001;7(3):209-12. doi: 10.1007/BF03032351.

DOI:10.1007/BF03032351
PMID:11692148
Abstract

Cellular proliferation programmed cell death (apoptosis) are associated with tumor growth in general, and prostate cancer growth in particular. The aim of this study was to examine the expression of the apoptosis regulating genes bcl-2 and p53 and Gleason score in core needle biopsy specimens of prostate cancer using immunohistochemistry. We studied bcl-2 and p53 expression in 12 cases of low grade (Gleason score 2-5), 12 cases of intermediate grade (Gleason score 6-7) and 8 cases of high grade (Gleason score 8-10) prostate cancer. Overexpression of bcl-2 was noted in 3 of 32 patients (9.32%). One of them was high grade; others were intermediate grades. Expression of p53 was observed in 3 of low grades; others were high grade. The statistical analysis of present data suggest that there is no significant relation between p53 and bcl-2 expression and Gleason score in prostate cancer.

摘要

细胞增殖和程序性细胞死亡(凋亡)通常与肿瘤生长相关,尤其是前列腺癌的生长。本研究的目的是使用免疫组织化学方法检测前列腺癌粗针穿刺活检标本中凋亡调节基因bcl-2和p53的表达以及Gleason评分。我们研究了12例低级别(Gleason评分2-5)、12例中级别(Gleason评分6-7)和8例高级别(Gleason评分8-10)前列腺癌中bcl-2和p53的表达。32例患者中有3例(9.32%)出现bcl-2过表达。其中1例为高级别,其他为中级别。低级别中有3例观察到p53表达;其他为高级别。对当前数据的统计分析表明,前列腺癌中p53和bcl-2表达与Gleason评分之间无显著关系。

相似文献

1
Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer.前列腺癌中凋亡调节蛋白(bcl-2和p53)与Gleason评分之间的关系
Pathol Oncol Res. 2001;7(3):209-12. doi: 10.1007/BF03032351.
2
Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.雄激素受体表达与前列腺癌细胞凋亡及细胞周期相关蛋白表达的关系
Pathol Oncol Res. 2004;10(1):37-41. doi: 10.1007/BF02893407. Epub 2004 Mar 18.
3
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.通过Ki67免疫组化染色测量的肿瘤生长分数是小体积或低级别前列腺癌术前前列腺活检中的一个独立预后因素。
Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174.
4
Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation.前列腺癌的组织学类型、免疫组化特征与 Gleason 分级之间的相关性。
Exp Oncol. 2009 Dec;31(4):246-9.
5
Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation.Bcl-2、Bax和p53在高级别前列腺上皮内瘤变和局限性前列腺癌中的表达:与细胞凋亡和增殖的关系。
Prostate. 1998 Dec 1;37(4):223-9. doi: 10.1002/(sici)1097-0045(19981201)37:4<223::aid-pros3>3.0.co;2-o.
6
Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.经尿道前列腺切除术中偶然发现的局限性前列腺腺癌中DNA倍体、bcl-2和p53的预后价值。
J Urol. 2006 Dec;176(6 Pt 1):2701-5. doi: 10.1016/j.juro.2006.07.133.
7
Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.通过TUNEL技术检测临床局限性前列腺癌在联合内分泌治疗前后的细胞凋亡情况。
J Clin Pathol. 1997 May;50(5):384-8. doi: 10.1136/jcp.50.5.384.
8
Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.在前列腺癌中,粗针穿刺活检中的Ki67标记指数可独立预测肿瘤特异性生存率。
Hum Pathol. 1998 Sep;29(9):949-54. doi: 10.1016/s0046-8177(98)90199-x.
9
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.前列腺癌中的肿瘤分级、增殖、凋亡、微血管密度、p53和bcl-2:移行区和外周区肿瘤之间的差异
Eur Urol. 2002 Jan;41(1):40-6. doi: 10.1016/s0302-2838(01)00021-5.
10
bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer.bcl-2过表达与p53蛋白积累相结合与激素难治性前列腺癌相关。
Br J Cancer. 1996 Oct;74(8):1258-62. doi: 10.1038/bjc.1996.526.

引用本文的文献

1
Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate.细胞周期蛋白 D1 免疫反应和 AgNOR 染色在前列腺良恶性病变评估中的作用。
Prostate Int. 2014;2(2):90-6. doi: 10.12954/PI.14041. Epub 2014 Jun 30.
2
The effects of melatonin and the antioxidant defence system on apoptosis regulator proteins (Bax and Bcl-2) in experimentally induced varicocele.褪黑素和抗氧化防御系统对实验性诱导精索静脉曲张中凋亡调节蛋白(Bax和Bcl-2)的影响。
Urol Res. 2004 Jun;32(3):204-8. doi: 10.1007/s00240-004-0403-0. Epub 2004 Feb 6.

本文引用的文献

1
p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?前列腺癌区域淋巴结转移中p53的改变:进展的标志物?
Cancer. 1999 Jun 1;85(11):2455-9.
2
p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.p53蛋白过表达与局部复发性前列腺癌患者放疗后细胞增殖增加有关。
Cancer. 1999 Mar 15;85(6):1293-9.
3
Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.
Ki-67、p53和Bcl-2表达在伴有淋巴结转移的前列腺癌患者中的预后意义:一项回顾性免疫组织化学分析
Pathol Int. 1998 Jan;48(1):41-6. doi: 10.1111/j.1440-1827.1998.tb03826.x.
4
Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity.无论是放射治疗还是根治性前列腺切除术后出现的局部复发性前列腺肿瘤,其Ki-67标记指数、p53和bcl-2免疫反应性均有变化。
J Urol. 1998 May;159(5):1437-43. doi: 10.1097/00005392-199805000-00004.
5
Combined analysis with Bcl-2 and P53 immunostaining predicts poorer prognosis in prostatic carcinoma.
J Urol. 1997 Dec;158(6):2278-83. doi: 10.1016/s0022-5347(01)68235-1.
6
Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.前列腺癌转移的分子标志物。开发预测前列腺癌侵袭性的诊断方法。
Am J Pathol. 1997 May;150(5):1511-21.
7
p53, the cellular gatekeeper for growth and division.p53,细胞生长和分裂的守门人。
Cell. 1997 Feb 7;88(3):323-31. doi: 10.1016/s0092-8674(00)81871-1.
8
Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors.生殖细胞肿瘤中凋亡程度与p53和bcl-2表达的关系
Hum Pathol. 1996 Nov;27(11):1221-6. doi: 10.1016/s0046-8177(96)90318-4.
9
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.凋亡调节蛋白p53和bcl-2水平升高是手术治疗的临床局限性前列腺癌的独立预后生物标志物。
J Urol. 1996 Oct;156(4):1511-6.
10
The biologic dilemma of early carcinoma of the prostate.前列腺早期癌的生物学困境
Cancer. 1996 Jul 15;78(2):326-9. doi: 10.1002/(SICI)1097-0142(19960715)78:2<326::AID-CNCR21>3.0.CO;2-X.